These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

44 related items for PubMed ID: 8649343

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Phospho-dephospho-control by insulin is mimicked by a phospho-oligosaccharide in adipocytes.
    Alemany S, Mato JM, Strålfors P.
    Nature; ; 330(6143):77-9. PubMed ID: 3313056
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Wortmannin converts insulin but not oxytocin from an antilipolytic to a lipolytic agent in the presence of forskolin.
    Fain JN, Gokmen-Polar Y, Bahouth SW.
    Metabolism; 1997 Jan; 46(1):62-6. PubMed ID: 9005971
    [Abstract] [Full Text] [Related]

  • 25. High expression of beta-adrenergic receptor kinase in human peripheral blood leukocytes. Isoproterenol and platelet activating factor can induce kinase translocation.
    Chuang TT, Sallese M, Ambrosini G, Parruti G, De Blasi A.
    J Biol Chem; 1992 Apr 05; 267(10):6886-92. PubMed ID: 1339451
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Counter-regulation by insulin and isoprenaline of a prominent fat-associated phosphoprotein doublet in rat adipocytes.
    Mooney RA, Bordwell KL.
    Biochem J; 1991 Mar 01; 274 ( Pt 2)(Pt 2):433-8. PubMed ID: 1848760
    [Abstract] [Full Text] [Related]

  • 28. Effects of peroxovanadate and vanadate on insulin binding, degradation and sensitivity in rat adipocytes.
    Yu ZW, Posner BI, Smith U, Eriksson JW.
    Biochim Biophys Acta; 1996 Jan 10; 1310(1):103-9. PubMed ID: 9244182
    [Abstract] [Full Text] [Related]

  • 29. Isoproterenol decreases LDL receptor expression in rat adipose cells: activation of cyclic AMP-dependent proteolysis.
    Kraemer FB, Natu V, Singh-Bist A, Patel S, Komaromy MC, Medicherla S, Azhar S, Sztalryd C.
    J Lipid Res; 1996 Feb 10; 37(2):237-49. PubMed ID: 9026523
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Enhanced desensitization and phosphorylation of the beta 1-adrenergic receptor in rat adipocytes by peroxovanadate.
    Bahouth SW, Gokmen-Polar Y, Coronel EC, Fain JN.
    Mol Pharmacol; 1996 Jun 10; 49(6):1049-57. PubMed ID: 8649343
    [Abstract] [Full Text] [Related]

  • 34. Mechanisms of inhibition of lipolysis by insulin, vanadate and peroxovanadate in rat adipocytes.
    Castan I, Wijkander J, Manganiello V, Degerman E.
    Biochem J; 1999 Apr 15; 339 ( Pt 2)(Pt 2):281-9. PubMed ID: 10191258
    [Abstract] [Full Text] [Related]

  • 35. Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation.
    Yu ZW, Jansson PA, Posner BI, Smith U, Eriksson JW.
    Diabetologia; 1997 Oct 15; 40(10):1197-203. PubMed ID: 9349602
    [Abstract] [Full Text] [Related]

  • 36. Glucose-dependent insulin modulation of oscillatory lipolysis in perifused rat adipocytes.
    Getty-Kaushik L, Richard AM, Corkey BE.
    Obes Res; 2005 Dec 15; 13(12):2058-65. PubMed ID: 16421338
    [Abstract] [Full Text] [Related]

  • 37. Potent and selective human beta(3)-adrenergic receptor antagonists.
    Candelore MR, Deng L, Tota L, Guan XM, Amend A, Liu Y, Newbold R, Cascieri MA, Weber AE.
    J Pharmacol Exp Ther; 1999 Aug 15; 290(2):649-55. PubMed ID: 10411574
    [Abstract] [Full Text] [Related]

  • 38. Enhanced desensitization and phosphorylation of the beta 1-adrenergic receptor in rat adipocytes by peroxovanadate.
    Bahouth SW, Gokmen-Polar Y, Coronel EC, Fain JN.
    Mol Pharmacol; 1996 Jun 15; 49(6):1049-57. PubMed ID: 8649343
    [Abstract] [Full Text] [Related]

  • 39. Mechanisms of inhibition of lipolysis by insulin, vanadate and peroxovanadate in rat adipocytes.
    Castan I, Wijkander J, Manganiello V, Degerman E.
    Biochem J; 1999 Apr 15; 339 ( Pt 2)(Pt 2):281-9. PubMed ID: 10191258
    [Abstract] [Full Text] [Related]

  • 40. Peroxovanadate and insulin action in adipocytes from NIDDM patients. Evidence against a primary defect in tyrosine phosphorylation.
    Yu ZW, Jansson PA, Posner BI, Smith U, Eriksson JW.
    Diabetologia; 1997 Oct 15; 40(10):1197-203. PubMed ID: 9349602
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 3.